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Objective: Leukocyte adhesion deficiency (LAD) is a rare, autosomal recessive 
inherited disorder; LAD-I which is the most common type, occurs due to mutations in 
the CD18 gene. This mutation down-regulates the expression of ß2 integrin leukocyte 
cell surface molecules, which are necessary for the adhesion of leukocytes to endothelial 
cells, transendothelial migration, and chemotaxis. The major symptoms are recurrent 
severe bacterial infections without pus formation, recurrent or progressive necrotizing 
soft tissue infections, marked leukocytosis and severe progressive periodontitis 
accompanied by alveolar bone loss, periodontal pockets, and partial or total early loss of 
primary and permanent teeth. 
Cases: Herein, we report a case of moderate LAD-I in a nine year-old boy with severe 
alveolar bone loss and aggressive periodontitis. For several years, approximately every 
month, the patient was followed up to evaluate the status of primary and permanent 
dentition. During these visits, scaling and root planing were performed and severely 
mobile teeth were extracted. The patient is now under regular follow up.  
Conclusion: This case confirms the need for interactions between the medical groups to 
identify and manage medically compromised children with rare diseases. It is important 
to include LAD in the differential diagnoses of children presenting with periodontal 
disease. Early correct diagnosis of LAD has various benefits for patients.  
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Several hematologic and genetic disorders 
are related to the development of 
periodontitis. A large number of reports are 
available on the effects of systemic 
conditions on the periodontium; however, a 
limited number of them have investigated 
the exact mechanism of the effect of such 
disorders on periodontal tissues (1, 2). It has 
been assumed that the main effect of these 
disorders is mediated by the alterations in 
host defense mechanisms, which have been 
clearly explained for some disorders, 
including neutropenia and LAD, but are less 
understood for multifaceted syndromes. 
Many of such disorders clinically manifest 
at an early age and may be misdiagnosed as 
aggressive forms of periodontitis with rapid 
attachment loss and the potential for early 
tooth loss. Periodontitis as a manifestation 
of a systemic disease refers to cases of 
periodontitis not caused by local factors 
such as high amount of dental plaque or 
calculus (3). In 1987, the term LAD was 
coined by Anderson and Springer and they 
described the clinical spectrum of this 
condition (4). Leukocyte adhesion 
deficiency is a rare, autosomal recessive 
inherited disorder affecting one/1,000,000 
individuals. In general, there are three types 
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of LADs (5): LAD-I, which is the most 
common type, occurs due to mutations in a 
region of the CD18 gene on chromosome 
21q22.3 (6, 7). The integrins are cell 
membrane receptors and include α and β 
subunits, which mediate adhesion in all body 
tissues (8). This mutation leads to absence or 
severe reduction of expression of ß2 integrin 
molecules on leukocyte cell surface, which 
are necessary for adhesion of leukocytes to 
endothelial cells, transendothelial migration, 
and chemotaxis (6, 9). The major symptoms 
of the syndrome include delayed separation 
of the umbilical cord, recurrent severe 
bacterial infections without pus formation, 
recurrent or progressive necrotizing soft 
tissue infections, marked leukocytosis 
(especially increase of neutrophils), and 
severe periodontitis with early loss of 
primary teeth followed by the early loss of 
permanent teeth (10). Patients with LAD-II 
show a deficiency in fucosylation of 
different cell surface glycoproteins, some of 
which act as ligands for selectins. 
Consequently, the initial “rolling” of the 
leukocytes, which is mediated by a 
reversible contact between L-selectins on the 
leukocytes and E- or P-selectins on the 
endothelial cells with their respective 
sialylated fucosyl ligands on the opposite 
cells, is disturbed (10). The LAD-II is a 
disease characterized by impaired 
fucosylation, recurrent infections, persistent 
leukocytosis and severe mental and growth 
retardations (5, 11). The LAD-III syndrome 
is also quite rare and is characterized by the 
immunodeficiency of LAD-I and serious 
bleeding disorders (6). In this type of 
syndrome, the adhesive ability of ß1, ß2, and 
ß3 integrins is impaired and, as a result, the 
patients suffer from recurrent infections in 
addition to severe bleeding (2, 5). This 
syndrome is characterized by pus-free tissue 
infections and massive hyperleukocytosis 
(>30,000/μL) and is diagnosed by 
immunofluorescence and functional assays 
for detecting ß2 integrin (7). Overall, 
various treatments are listed for these 
patients. Hematopoietic stem cell 
transplantation, which has a quite high 
success rate, is considered as the gold 
standard for this condition (6). In severely ill 
patients with refractory infections, 
allogeneic granulocyte transfusion has been 
beneficial as well. Despite the risk of graft-
versus-host disease, allogeneic bone marrow 
transplantation has been reported to be 
successful in treatment of this disorder (12). 
Mobile teeth may be extracted. In case of 
early alveolar bone loss, generalized 
mobility will occur and the clinician should 
examine and suggest the extraction of highly 
mobile teeth, which cause recurrent 
infections (6). It is also necessary to do 
patient follow up in order to ensure adequate 
oral health. Nonetheless, retroviral mediated 
gene replacement therapy might be one of 
the future treatment strategies for this 
syndrome. This approach may be highly 
useful for LAD-I since it is a monogenic 
disorder involving hematopoiesis, and even 
a minor correction would lead to clinical 
benefits (13). Herein, we report a case of 
moderate LAD-I in a nine year-old boy with 





The patient was a nine year-old boy, first 
visited at the Department of Pediatric 
Dentistry, Shiraz University of Medical 
Sciences, Shiraz, Iran at the age of five and a 
half years. His parents reported early loss of 
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primary dentition and gingival problems. 
The patient was hospitalized at the age of 
nine months for five days because of high 
fever and was diagnosed with LAD mainly 
based on developing bedsores after a short 
time. According to the laboratory test results 
showing low level of CD11 and CD 18, and 
the parents' consanguineous marriage (they 
were first –degree cousins), the diagnosis of 
moderate LAD-I was made. Multiple skin 
scars particularly on the elbows showing 
previous skin abscesses and infections were 
also detected (Figure 1). Moreover, oral 
examination revealed tooth mobility and 
inflammation of the gums. Furthermore, 
early loss of most primary teeth was noted 
along with primary canines and molars with 
grade II and III mobility (Figure 2). The 
permanent first molars were erupted with 
less than two/thirds of their roots being 
formed. Panoramic radiograph showed 
severe alveolar bone loss and aggressive 
periodontitis (Figure 3). The bleeding index 
was 100%.  Periodontal pockets of maxillary 
and mandibular molars were 5 and 7mm, 
respectively. The clinical attachment loss in 




Figure 2,3- linical and Panoramic views show 
severe alveolar bone loss and aggressive 
periodontitis. 
To prevent caries, the clinician performed 
professional oral prophylaxis, fluoride 
therapy, and fissure sealant therapy of the 
first permanent molars at the age of seven. 
The parents were then advised to provide 
oral hygiene, including brushing his teeth 
with Paradontax dentifrice 
(Glaxosmithkline, London, England) twice 
daily; antiseptic mouth rinse (10% 
povidone-iodine; RazianeSabz, Tehran, Iran) 
was also prescribed. However, owing to the 
patient’s refusal to use the mouth rinse, Irsha 
(Donyaye Behdasht, Tehran, Iran) was later 
prescribed. For skin ulcers, antibiotics, such 
as clindamycin (300 mg q6h; Kosar 
Pharmaceuticals, Tehran, Iran) were 
prescribed. One day before the dental 
treatments, ampicillin (125mg/5mL q6h  
suspension; Kosar Pharmaceuticals, Tehran, 
Iran) and metronidazole (125mg/5mL 
suspension q8h; Alborzdarou, Tehran, Iran) 
were administered as prophylaxis and 
continued for the next four days.  
For several years, approximately every 
month, the patient was visited at the 
Department of Pediatric Dentistry to 
evaluate the status of the primary and 
permanent dentition (Figure 4). During the 
follow-up visits, scaling and root planing 
was performed. In addition, the patient's 
severely mobile primary mandibular canines 
and primary right lateral incisor were 
extracted. Six months later, upper primary 
canines with mobility grade III at the age of 
seven were extracted. Anterior mandibular 
teeth showed gingival inflammation in the 
next follow up session. Since the patient had 
pain during plaque control, using a topical 
anesthetic gel (20% benzocaine) before 
tooth brushing was recommended. Monthly 
follow up examinations were affected by the 
patient's hospitalizations because of skin 
abscesses. Recently, the mobile mandibular 
right first permanent molar was extracted 
after taking antibiotics since it was severely 
mobile and had a periapical abscess. 
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Figure4-Clinical view in follow up visit 
At present, the patient is under regular 
follow up. Due to his improved condition in 
the recent years, bone marrow 
transplantation has not yet been considered 




The LAD-I is a rare, inherited, autosomal 
recessive, immunodeficiency disorder 
resulting from the combined absence of 
expression of leukocyte integrins LFA-1, 
Mac-1, and pl50, 95 on the surface of 
leukocytes (6). This type of LAD affects one 
per 1,000,000 individuals and usually occurs 
during infancy or early childhood with 
severe recurrent bacterial infections, lack of 
pus formation, and impaired wound healing 
(14). The primarily involved areas include 
the skin, oral mucosa and gastrointestinal 
tract (5). The disease is categorized into two 
groups of severe (<1% expression of CD18) 
and moderate (1–30% expression of CD18) 
phenotypes according to the degree of 
expression of CD18 (6). The patients with 
moderate phenotype are usually diagnosed 
late. Because of extensive necrotizing 
bacterial infections, the more severe 
phenotype usually leads to mortality before 
the age of two. On the other hand, the 
patients with moderate phenotype live a 
longer life with 75% dying before the age of 
38. The quality of life of such patients is 
usually poor and involves recurrent viral and 
bacterial infections, including periodontitis, 
necrotic skin lesions, and ulcers in the 
gastrointestinal tract (5). 
In general, recurrent oral ulcers are 
commonly found in this syndrome. In spite 
of preventive therapy, rapidly progressive 
juvenile periodontitis is prevalent due to the 
severity of the disease (15). Progressive 
periodontal disease in children with LAD-1 
may result in severe systemic infections and 
death; thus, early diagnosis with proper 
intervention is critical to improve the 
prognosis. Furthermore, in case of 
inflammation, active process of tooth 
eruption may be affected (8, 11). The most 
common pathogens causing infection in 
LAD include Staphylococcus aureus, 
Pseudomonas spp., gram-negative enteric 
species and Candida albicans (5). Oral 
candidiasis is also a frequently observed 
complication, which must be treated 
promptly (16). Considering the chronicity of 
the disease and risk of serious 
complications, patients suffering from LAD 
may have numerous hospital admissions and 
long hospitalization periods to receive 
supportive medical treatments (5). Delayed 
cord separation may occur in healthy infants, 
while it is often accompanied by acute 
omphalitis in patients with LAD type I. 
Overall, cord separation is considered 
normal or delayed when it takes place after 
two or three weeks of age, respectively (10). 
In case no evidence of even the initiation of 
cord separation from the umbilicus is found 
after four weeks, LAD should be suspected. 
Although an association has been reported 
between delayed umbilical cord separation 
and leukocyte dysfunction in many cases, it 
is not always accompanied by leukocyte 
adhesion (5) and this was not the case in our 
patient either. Delayed umbilical cord 
separation is not observed in LAD type II 
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(13). Because of poor wound healing and 
defective neutrophil function, gingival 
health maintenance is difficult for patients; 
therefore, dental care must be emphasized 
by a dental care provider for the remaining 
teeth. Treatment approaches in these patients 
should include prevention of local (dental) 
and systemic infections. Defective 
expression of CD18 results in enhanced 
susceptibility to bacterial infections (caused 
by neutrophil dysfunction) and viral diseases 
since CD18 plays a major role in cytotoxic T 
cell activity (8). Thus, a combination of 
wide-spectrum antibiotics, such as 
trimethoprim-sulfamethoxazole, and 
acyclovir are used in such cases. 
Nevertheless, in spite of optimal prophylaxis 
to prevent systemic infections, oral disease 
is still a problem in LAD-I patients and 
requires specific measures, including 
reinforcement of oral hygiene, prevention of 
local infections (by using chlorhexidine), 
and periodontal disease follow up (8). 
Hematopoietic stem cell transplantation, 
which has a quite high success rate, is 
considered as the gold standard treatment for 
this condition (6). In severely ill patients 
with refractory infections, allogeneic 
granulocyte transfusion has been beneficial 
as well.  
Considering the high prevalence of primary 
immunodeficiency in the Iranian population 
(9) as well as the high rate of 
consanguineous marriage in Iran, more 
attention should be paid to public education 
and awareness in this regard. Moreover, 
since LAD has a genetic etiology, genetic 
counseling should be provided for the 
affected children's parents, siblings, and the 
extended family. Prenatal diagnosis should 
also be taken into account for the patient’s 
siblings who are at risk of having children 





It is important to include LAD in the 
differential diagnoses of children presenting 
with periodontal disease. Early, appropriate 
diagnosis of LAD provides various benefits 
for the patients as well as their families and 
in this context, cooperation between 
different medical groups is essential. 
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